GWT-Tud GmbH

Coswig 9 trials 5 recruiting

9 Registered trials

5 Currently recruiting

Organisation

GWT-Tud GmbH

Location

Coswig, Germany

Identifier

ORG-100009621

Address

Neucoswiger Strasse 21, 01640, Germany

Departments

Department of Pneumology
Klinik für Innere Medizin und Pneumologie
lnnere Abteilung / Pneumologie
Pneumologie
Prüfstelle der GWT
Prüfstelle der GWT am Fachkrankenhaus Coswig
Zentrum für Pneumologie, Allergologie
Zentrum für Pneumologie, Allergologie,

Clinical trials at this site (9)

Search interface

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis Recruiting

2023-503699-25-00 Progressive Pulmonary Fibrosis 5 2024-07-15
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis Recruiting

2023-503697-21-01 Idiopathic pulmonary fibrosis 5 2024-06-24
A study to find out whether BI 765423 has an effect on lung function in people with idiopathic pulmonary fibrosis (IPF) with or without stan… Recruiting

2025-520658-12-00 Idiopathic Pulmonary Fibrosis (IPF) 4 2025-11-20
A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects … Recruiting

2023-504904-26-00 Progressive Pulmonary Fibrosis 5 2025-04-07
A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10… Recruiting

2023-507353-15-00 idiopathic pulmonary fibrosis (IPF) 5 2024-09-10
Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease Ended

2023-504471-25-00 Fibrotic Lung Disease 5 2024-03-01
A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the tr… Ended

2023-506185-31-00 Idiopathic pulmonary fibrosis (IPF) 10 2024-07-18
A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects … Ended

2024-514761-19-00 Idiopathic Pulmonary Fibrosis 5 2023-01-25
A study to find out whether BI 1015550 improves lung function in people with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) Ended

2024-512803-37-00 Progressive Fibrosing Interstitial Lung Diseases (PF-IL 5 2022-10-05